Probiotic Use and Psoriatic Arthritis Disease Activity

by Madison Grinnell, Alexis Ogdie, Kristin Wipfler, Kaleb Michaud
Published 2020-06-01

Smartphone-based behavioral monitoring and patient-reported outcomes in adults with rheumatic and musculoskeletal disease

by Elizabeth Mollard, Sofia Pedro, Rebecca Schumacher, Kaleb Michaud
Published 2022-06-01

Estimation of Minimally Important Differences and Patient Acceptable Symptom State Scores for the Patient‐Reported Outcomes Measurement Information System Pain Interference Short F...

by Patricia Katz, Carol L. Kannowski, Luna Sun, Kaleb Michaud
Published 2020-06-01

The Impact of Asthma and Chronic Obstructive Pulmonary Disease (COPD) on Patient‐Reported Outcomes in Systemic Lupus Erythematosus (SLE)

by Patricia Katz, Sofia Pedro, Laura Trupin, Edward Yelin, Kaleb Michaud
Published 2021-04-01

Risk factors for venous thromboembolism and atherosclerotic cardiovascular disease: do they differ in patients with rheumatoid arthritis?

by Gulsen Ozen, Sofia Pedro, Kaleb Michaud, Rebecca Schumacher, Teresa Simon
Published 2021-08-01

Safety of abatacept compared with other biologic and conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: data from an observational...

by Gulsen Ozen, Sofia Pedro, Rebecca Schumacher, Teresa A. Simon, Kaleb Michaud
Published 2019-06-01

Side Effects of Methotrexate and Tumor Necrosis Factor Inhibitors: Differences in Tolerability Among Patients With Psoriatic Arthritis and Rheumatoid Arthritis

by Alexis Ogdie, Ervant J. Maksabedian Hernandez, Yomei Shaw, Bradley Stolshek, Kaleb Michaud
Published 2022-11-01

Treatment Adherence and Adherence Patterns of Tofacitinib and Self‐Injectable TNFi Use in People with Rheumatoid Arthritis

by Kaleb Michaud, Sofia Pedro, Eric Tousset, Rebecca Schumacher, Ekta Agarwal, Bernard Vrijens
Published 2024-02-01

Risk of Serious Infection in Patients With Rheumatoid Arthritis Treated With Biologic Versus Nonbiologic Disease‐Modifying Antirheumatic Drugs

by Gulsen Ozen, Sofia Pedro, Bryant R. England, Bella Mehta, Frederick Wolfe, Kaleb Michaud
Published 2019-09-01

Perspectives on Treatment Burden for Methotrexate and Tumor Necrosis Factor Inhibitors Among Patients With Psoriatic Arthritis and Rheumatoid Arthritis: A Qualitative Study

by Alexis Ogdie, Yomei Shaw, Michele Almonte, Ervant J. Maksabedian Hernandez, Bradley Stolshek, Kaleb Michaud
Published 2023-04-01

Rheumatic disease patient decision-making about COVID-19 vaccination: a qualitative analysis

by Yomei P. Shaw, Sara Hustek, Nina Nguyen, Makenzie Starlin, Kristin Wipfler, Beth I. Wallace, Kaleb Michaud
Published 2022-11-01

Estimates of Responsiveness, Minimally Important Differences, and Patient Acceptable Symptom State in Five Patient‐Reported Outcomes Measurement Information System Short Forms in S...

by Patricia Katz, Sofia Pedro, Evo Alemao, Jinoos Yazdany, Maria Dall'Era, Laura Trupin, Stephanie Rush, Kaleb Michaud
Published 2020-01-01

Posttraumatic Stress Disorder, Depression, Anxiety, and Persistence of Methotrexate and TNF Inhibitors in Patients with Rheumatoid Arthritis

by Luke W. Desilet, Bryant R. England, Kaleb Michaud, Jennifer L. Barton, Ted R. Mikuls, Joshua F. Baker
Published 2020-10-01

Experiences of Patients With Rheumatic Diseases in the United States During Early Days of the COVID‐19 Pandemic

by Kaleb Michaud, Kristin Wipfler, Yomei Shaw, Teresa A. Simon, Adam Cornish, Bryant R. England, Alexis Ogdie, Patricia Katz
Published 2020-06-01

OPEX: Development of a novel overall patient experience measure to facilitate interpretation of comparison effectiveness studies.

by Liana Fraenkel, Zhenglin Wei, Christine Ramsey, Carole Wiedmeyer, Kaleb Michaud, Tuhina Neogi, W Benjamin Nowell, Shilpa Venkatachalam, David A Broniatowski
Published 2021-01-01

Real‐World Adherence to Oral Methotrexate Measured Electronically in Patients With Established Rheumatoid Arthritis

by Kaleb Michaud, Bernard Vrijens, Eric Tousset, Sofia Pedro, Rebecca Schumacher, Gorana Dasic, Connie Chen, Ekta Agarwal, Maria E. Suarez‐Almazor
Published 2019-11-01

Patterns of Tumor Necrosis Factor Inhibitor (TNFi) Biosimilar Use Across United States Rheumatology Practices

by Nick Bansback, Jeffrey R. Curtis, Jie Huang, Zeling He, Michael Evans, Tracy Johansson, Kaleb Michaud, Gabriela Schmajuk, Katherine P. Liao
Published 2020-02-01

Relative Impact of Pain and Fatigue on Work Productivity in Patients with Rheumatoid Arthritis from the RA-BEAM Baricitinib Trial

by Kaleb Michaud, Janet E. Pope, Paul Emery, Baojin Zhu, Carol L. Gaich, Amy M. DeLozier, Xiang Zhang, Christina L. Dickson, Josef S. Smolen
Published 2019-06-01

Benefits of Autoantibody Enrichment in Early Rheumatoid Arthritis: Analysis of Efficacy Outcomes in Four Pooled Abatacept Trials

by Kaleb Michaud, Philip G. Conaghan, Sang Hee Park, Karissa Lozenski, Mirko Fillbrunn, Vadim Khaychuk, Elyse Swallow, John Vaile, Henry Lane, Ha Nguyen, Janet Pope
Published 2023-05-01

Conceptual model for the health technology assessment of current and novel interventions in rheumatoid arthritis.

by Evo Alemao, Maiwenn J Al, Annelies A Boonen, Matthew D Stevenson, Suzanne M M Verstappen, Kaleb Michaud, Michael E Weinblatt, Maureen P M H Rutten-van Mölken
Published 2018-01-01